Bayer was ordered to pay more than $2 billion by a jury in a Georgia state court in the latest legal case surrounding alleged ...

Bayer will provide a minimum of $300 million in R&D investments to the JV over the next five years, and will acquire a minority stake in CRISPR Therapeutics for $35 million in cash.

Bayer AG BAYRY recently announced that the FDA had accepted its supplemental new drug application (sNDA) seeking approval for ...

Bayer has told U.S. lawmakers it could stop selling Roundup weedkiller unless they can strengthen legal protection against ...

Even though sales of prostate cancer drug Nubeqa and chronic kidney disease medicine Kerendia are picking up, they are not as profitable as Xarelto. Bayer’s Xarelto blood thinner medicine once ...

Police are searching for an arsonist who set fire to the North Jersey home of an executive from the pharmaceutical giant ...

Later that year, a once-promising blood thinner flopped in a trial, leaving a massive gap in Bayer's drug development lineup. Late last year, the drugs and pesticides maker said weakness in global ...

Bayer has won U.S. Food and Drug Administration priority review for its application seeking expanded approval of its kidney-disease drug Kerendia in certain people with heart failure.